CRP and COVID-19: Since both elevated CRP levels [1,2] and reduced lymphocyte counts [4] are reportedly linked to an adverse prognosis in COVID-19 patients [1,2,4], LCR could potentially exploit the prognostic value of both markers in either a synergistic or additive fashion [9,16].